Deutsche Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Sell
785,783
-948,682
-55% -$15.1M ﹤0.01% 1026
2025
Q4
$28.2M Buy
1,734,465
+21,326
+1% +$348K 0.01% 789
2025
Q3
$25.6M Buy
1,713,139
+1,542,685
+905% +$18.8M 0.01% 784
2025
Q2
$1.99M Sell
170,454
-447,721
-72% -$4.07M ﹤0.01% 1713
2025
Q1
$4.59M Sell
618,175
-12,402
-2% -$95.3K ﹤0.01% 1286
2024
Q4
$3.78M Buy
630,577
+503,842
+398% +$2.78M ﹤0.01% 1477
2024
Q3
$649K Sell
126,735
-458,968
-78% -$2M ﹤0.01% 2321
2024
Q2
$2.12M Sell
585,703
-18,803
-3% -$59.7K ﹤0.01% 1605
2024
Q1
$1.94M Buy
604,506
+1,450
+0.2% +$5.61K ﹤0.01% 1678
2023
Q4
$2.95M Buy
603,056
+546,069
+958% +$2.49M ﹤0.01% 1480
2023
Q3
$311K Sell
56,987
-540,190
-90% -$3.57M ﹤0.01% 2490
2023
Q2
$4.01M Sell
597,177
-37,886
-6% -$282K ﹤0.01% 1322
2023
Q1
$5.61M Buy
635,063
+12,345
+2% +$109K ﹤0.01% 1197
2022
Q4
$4.76M Sell
622,718
-31,335
-5% -$244K ﹤0.01% 1235
2022
Q3
$4.66M Buy
654,053
+5,651
+0.9% +$53.2K ﹤0.01% 1240
2022
Q2
$5.25M Buy
648,402
+306,982
+90% +$2.7M ﹤0.01% 1258
2022
Q1
$4.74M Buy
341,420
+206,421
+153% +$3.25M ﹤0.01% 1450
2021
Q4
$3.79M Sell
134,999
-22,012
-14% -$675K ﹤0.01% 1605
2021
Q3
$5.34M Buy
157,011
+10,922
+7% +$395K ﹤0.01% 1469
2021
Q2
$5.97M Sell
146,089
-18,711
-11% -$727K ﹤0.01% 1420
2021
Q1
$6.63M Buy
164,800
+125,067
+315% +$6.77M ﹤0.01% 1401
2020
Q4
$2.35M Sell
39,733
-113,601
-74% -$5.86M ﹤0.01% 1831
2020
Q3
$7.46M Buy
153,334
+107,309
+233% +$4.51M 0.01% 1085
2020
Q2
$2.23M Sell
46,025
-359,678
-89% -$13.1M ﹤0.01% 1734
2020
Q1
$11.3M Buy
405,703
+384,326
+1,798% +$10.7M 0.01% 871
2019
Q4
$637K Buy
21,377
+13,750
+180% +$395K ﹤0.01% 2609
2019
Q3
$235K Buy
+7,627
New +$311K ﹤0.01% 3093

Other funds holding ADPT